Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)

GHK-Cu: Evidence Summary

Evidence summary for GHK-Cu across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.

Back to GHK-Cu overview
Indication Evidence Tier Trial Count Summary
Wound healing Tier C 3 Topical application accelerates wound closure in small trials
Skin aging / rejuvenation Tier C 4 Increases collagen synthesis and skin thickness in controlled studies
Hair loss Tier D 1 Preclinical evidence suggests follicle stimulation; human data limited